Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 5/20 | 0.58 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | SHBG | P04278 | 2/20 | 0.53 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.53 |
| ▸ | G6PD | P11413 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.52 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.52 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.52 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13265741 | 0.88 | SRD5A2 (0.62) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL7622300 | 0.88 | SRD5A2 (0.62) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL370474 | 0.88 | SRD5A2 (0.62) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL30332128 | 0.87 | SRD5A2 (0.61) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL14729818 | 0.87 | SRD5A2 (0.61) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL11213645 | 0.85 | SRD5A2 (0.59) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL13240146 | 0.83 | SRD5A2 (0.58) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL13378032 | 0.82 | AR (0.71) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL14726730 | 0.82 | AR (0.71) | SRD5A2SRD5A1MEN1KMT2ATDP1 | |
| SCHEMBL11515941 | 0.82 | SRD5A2 (0.65) | SRD5A2SRD5A1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3863708-B1 | MIXED IONIC CONDUCTORS AND CORRESPONDING DEVICES, SYSTEMS AND METHODS OF MAKING | BATTELLE MEMORIAL INSTITUTE (US) | 2024-09-11 | — | — | EP | claimed |
| US-20160008376-A1 | Compositions, Methods and Uses for Treating Gender-Biased Immune Disorders | BIOCOPEA LIMITED (GB) | 2016-01-14 | — | — | US | claimed |
| WO-2016005599-A1 | COMPOSITIONS, METHODS AND USES FOR TREATING GENDER-BIASED IMMUNE DISORDERS | BIOCOPEA LIMITED (GB) | 2016-01-14 | — | — | WO | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| CN-103284955-A | Long-acting progestational hormone controlled-release injection implant and preparation method thereof | SHANGHAI INST PLANNED PARENTHOOD RES | 2013-09-11 | — | — | CN | claimed |
| US-20130131027-A1 | PARENTERAL PHARMACEUTICAL FORM WHICH RELEASES AROMATSE INHIBITOR AND GESTAGENS, FOR THE TREATMENT OF ENDOMETRIOSIS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-05-23 | — | — | US | claimed |
| CN-103002873-A | Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis | Bayer Pharma AG | 2013-03-27 | — | — | CN | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| US-20110195114-A1 | TRANSDERMAL DELIVERY SYSTEMS FOR ACTIVE AGENTS | ANTARES PHARMA, IPL, AG | 2011-08-11 | — | — | US | claimed |
| WO-1991000095-A1 | COMPOSITIONS USEFUL AS CONTRACEPTIVES IN MALES | COHEN MICHAEL (NL) | 1991-01-10 | — | — | WO | claimed |
| CN-1047974-A | Compositions and methods for effecting contraception | COHEN MICHAEL (NL) | 1990-12-26 | — | — | CN | claimed |
| WO-1990014084-A1 | USE OF MELATONIN DERIVATIVES FOR EFFECTING CONTRACEPTION | COHEN MICHAEL (NL) | 1990-11-29 | — | — | WO | claimed |
| EP-0354921-A1 | COMPOSITIONS AND METHODS OF EFFECTING CONTRACEPTION AND CONTROL OF BREAST CANCER. | APPLIED MED RES (US) | 1990-02-21 | — | — | EP | claimed |
| US-4855305-A | Compositions and methods of effecting contraception utilizing melatonin | APPLIED MEDICAL RESEARCH (US) | 1989-08-08 | — | — | US | claimed |
| WO-1988007370-A1 | COMPOSITIONS AND METHODS OF EFFECTING CONTRACEPTION AND CONTROL OF BREAST CANCER | APPLIED MEDICAL RESEARCH, LTD. (US) | 1988-10-06 | — | — | WO | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4016270-A | Method for treating dysmenorrhea with a uterine therapeutic system | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-3942641-A | Dispensing packages containing novel cyclic progestogen-interrupted estrogen oral contraceptive regimens | SYNTEX CORPORATION (PM) | 1976-03-09 | — | — | US | claimed |
| US-3932635-A | Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens | SYNTEX CORPORATION (PM) | 1976-01-13 | — | — | US | claimed |